How can genomic data be used to tailor cancer treatments to individual patients?
October 23, 2024
The integration of genomic data into cancer treatment represents a transformative approach known as precision oncology, aimed at tailoring therapies to individual patients based on their unique genetic profiles. A pivotal aspect involves comprehensive molecular profiling to identify tumor-specific genetic aberrations, which are then matched to targeted therapies. This paradigm shift is supported by advances in technologies such as next-generation sequencing, which provide detailed insights into the genetic underpinnings of cancer, thereby facilitating the identification of actionable genetic mutations and pathways (1, 3, 4, 5, 6).
Despite the potential, several challenges persist. Tumor heterogeneity, the development of drug resistance, and the complexity of interpreting vast amounts of genomic data present significant hurdles. High-throughput technologies and computational tools, including artificial intelligence and machine learning, are crucial in managing and deciphering these data (1, 29, 33). The concept of personalized medicine extends beyond pure genomics to include multi-omics approaches—integrating genomics with transcriptomics, proteomics, and metabolomics—to refine patient stratification and therapy selection even further (3, 32).
Clinical implementation of personalized cancer therapies also necessitates developments in systems biology and patient-derived models, which can simulate responses and refine treatment strategies. The clinical decision-making process is increasingly supported by genomic decision-support tools that incorporate patient-specific bioinformatics data (27, 50, 35).
Furthermore, the successful deployment of precision oncology requires overcoming economic, regulatory, and logistical barriers such as data sharing, privacy concerns, and establishing reimbursement frameworks (8, 21, 23, 40). This approach aims for a broader adoption that fundamentally alters cancer care from a one-size-fits-all model to a patient-centric model, improving patient outcomes by reducing adverse effects and enhancing treatment efficacy (45, 49).
In conclusion, while the path to fully realizing the potential of genomics-based personalized cancer treatment is fraught with challenges, continued advancements in technology, data integration, and interdisciplinary collaboration will likely lead to a more precise and effective oncology practice (30, 50).
References
1. Dlamini, Zodwa, et al. "AI and precision oncology in clinical cancer genomics: From prevention to targeted cancer therapies—an outcomes based patient care." Informatics in Medicine Unlocked 31 (2022): 100965.
2. Matchett, Kyle B., et al. "Advances in precision medicine: tailoring individualized therapies." (2017): 146.
3. Malone, Eoghan R., et al. "Molecular profiling for precision cancer therapies." Genome medicine 12 (2020): 1-19.
4. Verma, Mukesh. "Personalized medicine and cancer." Journal of personalized medicine 2.1 (2012): 1-14.
5. West, Mike, et al. "Embracing the complexity of genomic data for personalized medicine." Genome research 16.5 (2006): 559-566.
6. Ellsworth, Rachel E., et al. "Breast cancer in the personal genomics era." Current genomics 11.3 (2010): 146-161.
7. Ginsburg, Geoffrey S., and Huntington F. Willard. "Genomic and personalized medicine: foundations and applications." Translational research 154.6 (2009): 277-287.
8. Nicholls, Stuart G., et al. "Personalized medicine and genome-based treatments: why personalized medicine individualized treatments." Clinical Ethics 9.4 (2014): 135-144.
9. Letai, Anthony. "Functional precision cancer medicine—moving beyond pure genomics." Nature medicine 23.9 (2017): 1028-1035.
10. Riedl, Jakob M., et al. "Molecular diagnostics tailoring personalized cancer therapy—an oncologist’s view." Virchows Archiv 484.2 (2024): 169-179.
11. Siu, Lillian L., et al. "Facilitating a culture of responsible and effective sharing of cancer genome data." Nature medicine 22.5 (2016): 464-471.
12. Wang, Richard C., and Zhixiang Wang. "Precision medicine: disease subtyping and tailored treatment." Cancers 15.15 (2023): 3837.
13. Vaske, Charles J., et al. "Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM." Bioinformatics 26.12 (2010): i237-i245.
14. Tajik, Parvin, and Patrick M. Bossuyt. "Genomic markers to tailor treatments: waiting or initiating?." Human genetics 130 (2011): 15-18.
15. Meric-Bernstam, Funda, and Gordon B. Mills. "Overcoming implementation challenges of personalized cancer therapy." Nature reviews Clinical oncology 9.9 (2012): 542-548.
16. Wulfkuhle, Julia D., et al. "Technology insight: pharmacoproteomics for cancer—promises of patient-tailored medicine using protein microarrays." Nature Clinical Practice Oncology 3.5 (2006): 256-268.
17. Mighton, Chloe, et al. "Development of patient profiles to tailor counseling for incidental genomic sequencing results." European Journal of Human Genetics 27.7 (2019): 1008-1017.
18. Streeter, Oscar E., Phillip J. Beron, and Prashant Natarajan Iyer. "Precision medicine: Genomic profiles to individualize therapy." Otolaryngologic Clinics of North America 50.4 (2017): 765-773.
19. Reimers, Marlies S., et al. "How does genome sequencing impact surgery?." Nature Reviews Clinical Oncology 11.10 (2014): 610-618.
20. Singla, Arun. "Precision Medicine: Tailoring Treatment to Individual Genetic Profiles." Shodh Sagar Journal for Medical Research Advancement 1.1 (2024): 27-37.
21. Borad, Mitesh J., and Patricia M. LoRusso. "Twenty-first century precision medicine in oncology: genomic profiling in patients with cancer." Mayo Clinic Proceedings. Vol. 92. No. 10. Elsevier, 2017.
22. Mateo, J., et al. "A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)." Annals of Oncology 29.9 (2018): 1895-1902.
23. Dienstmann, Rodrigo, Jordi Rodon, and Josep Tabernero. "Optimal design of trials to demonstrate the utility of genomically-guided therapy: putting precision cancer medicine to the test." Molecular oncology 9.5 (2015): 940-950.
24. Kerr, Anne, et al. Personalised cancer medicine: Future crafting in the genomic era. Manchester University Press, 2021.
25. Gonzalez-Angulo, Ana Maria, Bryan T. J. Hennessy, and Gordon B. Mills. "Future of personalized medicine in oncology: a systems biology approach." Journal of clinical oncology 28.16 (2010): 2777-2783.
26. Sasirekhamani, M., and S. Jamila Jasmin. "34. Bioinformatics and Personalized Medicine: Utilizing Genomic Data and Computational Approaches to Tailor Medical Treatments to Individual Patients." MOSAIC OF IDEAS: MULTIDISCIPLINARY REFLECTIONS (2024): 343.
27. Dienstmann, Rodrigo, et al. "Standardized decision support in next generation sequencing reports of somatic cancer variants." Molecular oncology 8.5 (2014): 859-873.
28. Krzyszczyk, Paulina, et al. "The growing role of precision and personalized medicine for cancer treatment." Technology 6.03n04 (2018): 79-100.
29. Aldea, M., et al. "Precision medicine in the era of multi-omics: can the data tsunami guide rational treatment decision?." ESMO open 8.5 (2023): 101642.
30. Yadav, Sunishtha Singh, et al. "The Role of Genetic Data Analysis for Precision Therapy in Cancer: Personalized Medicine Concept in Cancer Treatment." Research Anthology on Bioinformatics, Genomics, and Computational Biology. IGI Global, 2024. 1467-1483.
31. Pemovska, Tea, et al. "Individualized systems medicine strategy to tailor treatments for patients with chemorefractory acute myeloid leukemia." Cancer discovery 3.12 (2013): 1416-1429.
32. John, August, et al. "Patient-specific multi-omics models and the application in personalized combination therapy." Future Oncology 16.23 (2020): 1737-1750.
33. Qu, Zhonglin, et al. "Visual analytics of genomic and cancer data: a systematic review." Cancer informatics 18 (2019): 1176935119835546.
34. Dupont, Camille Amandine, et al. "Druggable genome and precision medicine in cancer: current challenges." The FEBS journal 288.21 (2021): 6142-6158.
35. Stricker, Thomas, Daniel V. T. Catenacci, and Tanguy Y. Seiwert. "Molecular profiling of cancer—the future of personalized cancer medicine: a primer on cancer biology and the tools necessary to bring molecular testing to the clinic." Seminars in oncology. Vol. 38. No. 2. WB Saunders, 2011.
36. Roukos, Dimitrios H. "Innovative genomic-based model for personalized treatment of gastric cancer: integrating current standards and new technologies." Expert review of molecular diagnostics 8.1 (2008): 29-39.
37. Andrei, Pietro, et al. "Integrated approaches for precision oncology in colorectal cancer: The more you know, the better." Seminars in cancer biology. Vol. 84. Academic Press, 2022.
38. Ross, Emily, et al. "Online accounts of gene expression profiling in early-stage breast cancer: Interpreting genomic testing for chemotherapy decision making." Health Expectations 22.1 (2019): 74-82.
39. Andre, F., et al. "Prioritizing targets for precision cancer medicine." Annals of Oncology 25.12 (2014): 2295-2303.
40. Denny, Joshua C., Laura K. Wiley, and Josh F. Peterson. "Use of Clinical Decision Support to Tailor Drug Therapy Based on Genomics." Clinical Decision Support Systems: Theory and Practice (2016): 209-226.
41. Torres, Gabriel Fernando, et al. "How clinically useful is comprehensive genomic profiling for patients with non-small cell lung cancer? A systematic review." Critical Reviews in Oncology/Hematology 166 (2021): 103459.
42. Restrepo, Juan Carlos, et al. "Advances in genomic data and biomarkers: revolutionizing NSCLC diagnosis and treatment." Cancers 15.13 (2023): 3474.
43. Peck, Richard W. "Precision medicine is not just genomics: the right dose for every patient." Annual review of pharmacology and toxicology 58.1 (2018): 105-122.
44. Chan, Carmen W. H., et al. "Novel strategies on personalized medicine for breast cancer treatment: an update." International journal of molecular sciences 18.11 (2017): 2423.
45. Ginsburg, Geoffrey S., and Jeanette J. McCarthy. "Personalized medicine: revolutionizing drug discovery and patient care." Trends in Biotechnology 19.12 (2001): 491-496.
46. Godman, Brian, et al. "Personalizing health care: feasibility and future implications." BMC medicine 11 (2013): 1-23.
47. Offit, Kenneth. "The future of clinical cancer genomics." Seminars in oncology. Vol. 43. No. 5. WB Saunders, 2016.
48. Gao, Jianjiong, et al. "Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal." Science signaling 6.269 (2013): pl1-pl1.
49. Hayes, Daniel F., et al. "Personalized medicine: risk prediction, targeted therapies and mobile health technology." BMC medicine 12 (2014): 1-8.
50. Kalamara, Angeliki, Luis Tobalina, and Julio Saez-Rodriguez. "How to find the right drug for each patient? Advances and challenges in pharmacogenomics." Current opinion in systems biology 10 (2018): 53-62.